However, in ERα+ breast cancer, the IDO1 promoter is silenced through hypermethylation, thus suggesting that ERα expression on breast cancer cells might impact their response to microenvironmental stimuli through epigenetic reprogramming (Dieci et al., 2021). The gene discussed is ESR1; the disease is breast carcinoma.